| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0009040> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0009247> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0009248> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0019993> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0021150> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0024874> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0035205> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0035435> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0035648> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0086027> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0199470> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C0242444> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C5392186> <https://research.tib.eu/covid-19/entity/32457048_HAS_TOPIC_C5392943>
?:authorAffiliation	[\'Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Division of Rheumatology, Inflammation, and Immunity, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA zswallace@partners.org.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Choi_Hyon_K> <https://research.tib.eu/covid-19/entity/D%27Silva_Kristin_M> <https://research.tib.eu/covid-19/entity/Fu_Xiaoqing> <https://research.tib.eu/covid-19/entity/Gravallese_Ellen_M> <https://research.tib.eu/covid-19/entity/Hsu_Tiffany> <https://research.tib.eu/covid-19/entity/Serling-Boyd_Naomi> <https://research.tib.eu/covid-19/entity/Sparks_Jeffrey_A> <https://research.tib.eu/covid-19/entity/Wallace_Zachary_S> <https://research.tib.eu/covid-19/entity/Wallwork_Rachel>
?:doi	10.1136/annrheumdis-2020-217888
?:doi	<https://research.tib.eu/covid-19/entity/10.1136/annrheumdis-2020-217888>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Comparative_Study> <https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_N.I.H.%2C_Extramural> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Annals of the rheumatic diseases
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32457048>
?:pmid	<https://research.tib.eu/covid-19/entity/32457048>
?:pmid	32457048
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	7.699
?:rankingScore_hIndex	198
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0035435_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C0587081_PROCESS_OF_C0030705>
?:title	Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \'hot spot\'.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Division of Rheumatology, Inflammation, and Immunity, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA zswallace@partners.org.\']

?:citedBy

-1

?:creator

?:doi

10.1136/annrheumdis-2020-217888

?:doi

<https://research.tib.eu/covid-19/entity/10.1136/annrheumdis-2020-217888>

?:hasPublicationType

?:journal

Annals of the rheumatic diseases

is ?:pmid of

<https://research.tib.eu/covid-19/entity/32457048>

?:pmid

<https://research.tib.eu/covid-19/entity/32457048>

?:pmid

32457048

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

7.699

?:rankingScore_hIndex

is ?:relation_isRelatedTo_publication of

?:title

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \'hot spot\'.

?:type

?:year

2020

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32457048>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32457048>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata